The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
NCT ID: NCT01370577
Last Updated: 2013-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
297 participants
OBSERVATIONAL
2011-07-31
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asthma Control in Elderly Patients With Montelukast
NCT01147510
General Risk Factors and Inflammatory Determinants in Older Patients With Asthma
NCT03278561
2nd_Computerized Asthma Specific Quality of Life(cAQOL)
NCT01227083
Factors for Predicting Severe Asthma Exacerbators in Adult Asthmatics: A Real Word- Effectiveness Study
NCT04563988
Efficacy of Bronchial Thermoplasty in Korean
NCT02031263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Total 300 subjects who was diagnosed with asthma
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with asthma, at least 1 year in duration.
Exclusion Criteria
* Patients taking immune therapy
* Patients previously enrolled/randomized in the present clinical trial
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hye Won Koo
Role: STUDY_DIRECTOR
AstraZeneca Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Wŏnju, Gangwon-do, South Korea
Research Site
Anyang-si, Gyeonggi-do, South Korea
Research Site
Suwon, Gyeonggi-do, South Korea
Research Site
Busan, Gyeonsangnam-do, South Korea
Research Site
Changwon, Gyeonsangnam-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RKR-XXX-2011/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.